Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
CEFTRIAXONE OGB HJ
GENERIC
Inhibits the synthesis of bacterial cell walls resulting in leakage of bacterial cells and bacterial lysis.
Available at :
Share this article
Related
Articles
Neoadjuvant Fulvestrant Yields Equal Effectiveness and Tolerability to Anastrozole
by dr. Johan Indra Lukito | 17 Mar 2026
Immunotherapy Plus Chemotherapy Improves Clinical Outcomes in Advanced Lung Cancer Study
by dr. Farica Noviana Kartawijaya | 25 Feb 2026
Osimertinib Plus Chemotherapy: Better Survival in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
by dr. Johan Indra Lukito | 14 Jan 2026
CDK Awards 2026
by dr. Dita Arccinirmala | 13 Jan 2026
Pregabalin Administration Reduces the Severity of Neuropathic Pain in Head and Neck Cancer Patients Undergoing Radiotherapy
by dr. Hastarita Lawrenti | 22 Dec 2025
Zerpidio Officially Launched in Thailand: A New Breakthrough in Lung Cancer Therapy
by Admin Kalbemed | 04 Aug 2025
CDK Awards 2025 Timeline Information
by dr. Vivian Keung | 18 Jul 2025
Cermin Dunia Kedokteran and Pharma Metric Labs Improve Doctors' Competence in Research Article Writing through “The Secret of Exceptional Research Article Writing” Workshop
by dr. Dita Arccinirmala | 23 Jun 2025
Kalbe Academia Anesthesia: The Silent Hero of the Operating Room
by dr. Karen Denisa | 02 Jun 2025
.
by dr. Dita Arccinirmala | 07 Apr 2025
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE